PubMed HealthSearch

PubMed · 8763104

[Subcortical dementia].

Abstract

Subcortical dementia, a concept introduced 20 years ago, is a clinical entity characterized by memory disorders, an impaired ability to manipulate acquired knowledge, important changes of personality (apathy, inertia or depression), slowed thought processes (or bradyphrenia). It is also marked by overwhelming signs of frontal dysfunction. Cognitive and behavioural disturbances are frequently combined to movement disorders (tremor, chorea, dystonia etc). Anatomical, clinical and scintigraphic data suggest that the frontal signs result from a disconnection of the frontal cortex from the basal ganglia. Therefore it is probably more accurate to use the term subcortico-frontal dementia. This pattern of dementia, clearly different from a cortical dementia as dementia of Alzheimer's disease, may be described in a wide range of diseases which mainly involve the subcortical areas: some cases of Parkinson's disease, Progressive Supranuclear Palsy, Huntington's disease, Wilson's disease, the état lacunaire, multiple sclerosis and so on. The concept of subcortical dementia has allowed a better understanding of the role of the basal ganglia and their cortical connections in cognition and behavior. Its neurochemical substrate remains poorly characterized, although the ascending dopaminergic and cholinergic pathways seem to be good candidates, at least in Parkinson's disease.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Sellal. 1996. [Subcortical dementia].. https://doi.org/10.1016/0248-8663(96)83744-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Parotid gland tumors: a comparison of postoperative radiotherapy techniques using three dimensional (3D) dose distributions and dose-volume histograms (DVHS).

PURPOSE: To compare different treatment techniques for unilateral treatment of parotid gland tumors. METHODS AND MATERIALS: The CT-scans of a representative parotid patient were used. The field size was 9 x 11 cm, the separation was 15.5 cm, and the prescription depth was 4.5 cm. Using 3D dose distributions, tissue inhomogeneity corrections, scatter integration (for photons) and pencil beam (for electrons) algorithms and dose-volume histogram (DVH), nine treatment techniques were compared. [1] unilateral 6 MV photons [2] unilateral 12 MeV electrons [3] unilateral 16 MeV electrons [4] an ipsilateral wedge pair technique using 6 MV photons [5] a 3-field AP (wedged), PA (wedged) and lateral portal technique using 6 MV photons [6] a mixed beam technique using 6 MV photons and 12 MeV electrons (1:4 weighting) [7] a mixed beam technique using 6 MV photons and 16 MeV electrons (1:4 weighting) [8] a mixed beam technique using 18 MV photons and 20 MeV electrons (2:3 weighting) [9] a mixed beam technique using 18 MV photons and 20 MeV electrons (1:1 weighting). RESULTS: Using dose-volume histograms to evaluate the dose to the contralateral parotid gland, the percentage of contralateral parotid volume receiving > or = 30% of the prescribed dose was 100% for techniques [1], [8] and [9], and < 5% for techniques [2] through [7]. Evaluating the "hottest" 5 cc of the ipsilateral mandible and temporal lobes, the hot spots were: 152% and 150% for technique [2], 132% and 130% for technique [6]. Comparing the exit doses, techniques [1], [8] and [9] contributed to > or = 50% of the prescribed dose to the contralateral mandible and the temporal lobes. Only techniques [2] and [6] kept the highest point doses to both the brain stem and the spinal cord below 50% of the prescribed dose. CONCLUSION: The single photon lateral field [1] and the mixed electron-photon beams [8] and [9] are not recommended treatment techniques for unilateral parotid irradiation because of high doses delivered to the contralateral parotid gland and high exit doses which are associated with Xerostomia. The en face electron beam technique [2] and the mixed electron-photon beam technique [6] are unacceptable due to the excessive dose heterogeneity to the contiguous normal structures. In spite of optimal dose fall-off achieved using the en face technique [3], most patients cannot tolerate the resulting high skin doses. We conclude that the ipsilateral wedge pair [4], the 3-field [5], and the mixed electron-photon beam [7] techniques are optimal techniques in providing relatively homogeneous dose distributions within the target area and for minimizing dose to the relevant normal structures.

Brain Diseases